Germans would value more trustworthy online health information
10.10.2025 11:20:26 CEST | news aktuell GmbH | Press Release
Most people these days look online for answers to questions on health. However, many have doubts on the integrity and quality of the information provided by social media platforms and AI chatbots. The Bertelsmann Stiftung would like to contribute to promoting reliable sources and increasing confidence in digital information on health by means of its new "InfoCure" international initiative.
Gütersloh, 10 October 2025. There is a strong desire on the part of people in Germany for high-quality and reliable information on health via the Internet. As many as 93% regard quality assurance on health and medical content found on the internet as important, as is shown by a representative survey conducted on behalf of the Bertelsmann Stiftung. One important reason for this could be the fact that 71% of Germans see their own digital competency on health issues as limited, as Bielefeld University's new "Health Literacy Survey" (HLS-GER 3) reveals. Many people have difficulty in assessing whether online information on health issues is trustworthy.
The significance of online sources in searching for information on health has increased over recent years. In the Bertelsmann Stiftung analysis, 87% of respondents say that they search online for information on health issues. Women do so more frequently than men by 91% to 83%, and those with higher educational qualifications more frequently than those with fewer qualifications, by 95% to 77%. Among the sources used, search engines are the most popular.
And among those who are aware of search engines, 87% use them to look for information in a health context, either frequently or occasionally. Healthcare web portals have a high rate of use: 54% of those who are aware of them make use of them frequently or occasionally. In the case of AI chatbots, the figure is 40%, with messenger services it is 36%, and with social media platforms 29%.
Reservations about the quality of digital health information
However, many people simultaneously harbour doubts concerning the trustworthiness of the digital responses provided on health issues. For example, 59% of respondents say that they feel they have received incorrect information frequently or occasionally when looking up health-related content on social media. With those using search engines for this purpose, the figure is 47%, and for AI chatbots 41%. By contrast, only 26% of those looking for information on health portals feel that they have received incorrect information frequently or occasionally.
"Incorrect or misleading information on health issues could cause great harm – both at an individual and at a societal level," Bertelsmann Stiftung executive member Daniela Schwarzer says. "For that reason, creating trustworthy sources on the internet for information on health on the internet is more important than ever, along with further developing it and identifying it in a transparent way," she adds.
The Bertelsmann Stiftung, along with the Austrian National Public Health Institute (Gesundheit Österreich GmbH) and Switzerland's Careum Stiftung, has set up the "InfoCure" non-profit initiative with the aim of assuring the quality of digital health information and countering the dissemination of false information. The intention is to establish an international certification system that vets providers of information on health objectively on the basis of scientific indicators. The certificate aims to assist digital applications to recognise trustworthy content on health issues. The "Nature Medicine Commission Quality Health Information for All" will take on the development of the indicators. This forum is made up of 24 international experts, including Daniela Schwarzer.
Contacts
Sebastian Schmidt-Kaehler, phone: +49 52 41 81 81 863
Email: sebastian.schmidt-kaehler@bertelsmann-stiftung.de
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Webasto Air Top Pro 25: a new, exceptionally quiet parking heater for campers22.10.2026 13:28:00 CEST | Press Release
Why should the camping season end just because summer is over? The colder months offer unique experiences—from skiing and snowshoeing to simply enjoying the winter landscape. To ensure your motorhome or campervan remains a comfortable retreat even in low temperatures, the right heating solution is crucial.
Polarise Launches Sovereign AI Cloud at NVIDIA GTC Berlin, Delivering Enterprise AI From Data Center to Application22.10.2026 10:00:00 CEST | Press Release
With Polarise Rise and Polarise Drive, the German AI provider extends its own European AI Factories into a full-stack sovereign cloud
Fiscal strength doesn't guarantee public goods delivery, US study finds21.10.2026 09:28:38 CEST | Press Release
New York/DNA - A newly released study of US state government performance found strong partisan and regional patterns within three pillars of governance: democratic accountability, state capacity and public goods provision. Yet, the US states’ outcomes differ in important ways from international comparisons, as the three governance dimensions show limited correlation, the researchers found. The report, “The Governance Performance of the Fifty States: The U.S. Berggruen Governance Index”, applies the research team’s “governance triangle” from past global country rankings to the 50 US states. The report has now been presented to the public at Columbia University in New York. “Unlike in the Berggruen Governance Index’s cross-national comparisons, where the three dimensions are broadly correlated, in the 50 U.S. states they often run counter to each other,” the authors conclude. “This may seem counterintuitive, as one might expect a well-governed state to finish high on all three and a poor
agineo expands partnership with ServiceNow, launches AI Control Tower as a Service20.10.2026 12:48:13 CEST | Press Release
New managed service provides transparency into the AI landscape and helps companies centrally manage AI, monitor risks and regulatory requirements, and highlight business benefits.
Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain20.10.2026 09:23:41 CEST | Press Release
Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain. Following successful Phase I results earlier this year demonstrating an excellent safety profile, the program has now progressed to Phase II. The randomized, double-blind, double-dummy, placebo- and active controlled, 2-part Phase II trial will evaluate the safety, tolerability and efficacy of this novel NOP agonist in patients post bunionectomy surgery. Grünenthal anticipates reporting results in early 2028.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom